Quantum Biopharma (QNTM) Retained Earnings (2018 - 2026)
Quantum Biopharma recorded quarterly Retained Earnings of -$211.8 million in Q1 2026, down 6.84% quarter-over-quarter from -$198.3 million in Q4 2025, and down 17.24% year-over-year from -$256.0 million in Q1 2025.
Quantum Biopharma's Retained Earnings history runs 9 years deep, the most recent figure standing at -$211.8 million for Q1 2026.
- In Q1 2026, Retained Earnings fell 17.24% year-over-year to -$211.8 million; the TTM figure through Mar 2026 stood at -$211.8 million (down 17.24% YoY), while the FY2025 annual figure was -$198.3 million, down 15.21% from the prior year.
- Retained Earnings came in at -$211.8 million for Q1 2026 at Quantum Biopharma, down from -$198.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$127.8 million in Q1 2022 to a low of -$211.8 million in Q1 2026.
- A 5-year average of -$165.4 million and a median of -$162.9 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings dropped 26.77% in 2022 and retreated 4.84% in 2024, its largest moves.
- Quantum Biopharma's Retained Earnings stood at -$144.2 million in 2022, then declined by 8.56% to -$156.5 million in 2023, then dropped by 9.97% to -$172.1 million in 2024, then fell by 15.21% to -$198.3 million in 2025, then decreased by 6.84% to -$211.8 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$211.8 million, -$198.3 million, and -$195.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.85 Mn |
| Dec 31, 2025 | -198.29 Mn |
| Sep 30, 2025 | -195.26 Mn |
| Jun 30, 2025 | -189.94 Mn |
| Mar 31, 2025 | -180.69 Mn |
| Dec 31, 2024 | -172.11 Mn |
| Sep 30, 2024 | -166.75 Mn |
| Jun 30, 2024 | -162.92 Mn |
| Sep 30, 2023 | -156.50 Mn |
| Jun 30, 2023 | -155.40 Mn |
| Mar 31, 2023 | -149.91 Mn |
| Dec 31, 2022 | -144.16 Mn |
| Sep 30, 2022 | -138.02 Mn |
| Jun 30, 2022 | -131.53 Mn |
| Mar 31, 2022 | -127.80 Mn |
| Dec 31, 2021 | -126.15 Mn |
| Sep 30, 2021 | -119.81 Mn |
| Jun 30, 2021 | -114.02 Mn |
| Mar 31, 2021 | -100.81 Mn |
| Dec 31, 2020 | -90.87 Mn |
| Sep 30, 2020 | -86.27 Mn |
| Jun 30, 2020 | -69.91 Mn |
| Mar 31, 2020 | -67.85 Mn |
| Dec 31, 2019 | -59.48 Mn |
| Dec 31, 2018 | -20.08 Mn |